Does RUCAPARIB CAMSYLATE Cause Prostatic specific antigen increased? 41 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 41 reports of Prostatic specific antigen increased have been filed in association with RUCAPARIB CAMSYLATE (Rubraca). This represents 0.5% of all adverse event reports for RUCAPARIB CAMSYLATE.
41
Reports of Prostatic specific antigen increased with RUCAPARIB CAMSYLATE
0.5%
of all RUCAPARIB CAMSYLATE reports
1
Deaths
4
Hospitalizations
How Dangerous Is Prostatic specific antigen increased From RUCAPARIB CAMSYLATE?
Of the 41 reports, 1 (2.4%) resulted in death, 4 (9.8%) required hospitalization.
Is Prostatic specific antigen increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RUCAPARIB CAMSYLATE. However, 41 reports have been filed with the FAERS database.
What Other Side Effects Does RUCAPARIB CAMSYLATE Cause?
Fatigue (2,494)
Nausea (2,219)
Malignant neoplasm progression (1,162)
Decreased appetite (787)
Constipation (763)
Diarrhoea (759)
Vomiting (759)
Asthenia (660)
Adverse event (571)
Carbohydrate antigen 125 increased (562)
What Other Drugs Cause Prostatic specific antigen increased?
ENZALUTAMIDE (3,731)
LEUPROLIDE (2,432)
ABIRATERONE (1,581)
RADIUM RA-223 DICHLORIDE (449)
RELUGOLIX (335)
BICALUTAMIDE (322)
DOCETAXEL (282)
APALUTAMIDE (251)
DENOSUMAB (220)
LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN (212)
Which RUCAPARIB CAMSYLATE Alternatives Have Lower Prostatic specific antigen increased Risk?
RUCAPARIB CAMSYLATE vs RUFINAMIDE
RUCAPARIB CAMSYLATE vs RUPATADINE
RUCAPARIB CAMSYLATE vs RUXOLITINIB
RUCAPARIB CAMSYLATE vs SABRIL
RUCAPARIB CAMSYLATE vs SACCHAROMYCES CEREVISIAE